On my recent visit to Colossal Biosciences’ new Dallas headquarters, still under construction ahead of its October opening, I asked for the latest update on one of the company’s most ambitious projects: the return of the woolly mammoth. After touring the new offices and labs, I sat down with Colossal Biosciences CEO and co-founder Ben Lamm to learn about the …
Read More »Colossal Biosciences Confirms 2028 Goal for Woolly Mammoth Birth
